Lataa...
Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer
Head and neck squamous cell carcinomas (HNSCCs) frequently harbor genomic mutations in cell death pathways. Nearly 30% of HNSCCs overexpress Fas-Associated Death Domain (FADD), with or without BIRC2/3 genes encoding cellular Inhibitor of Apoptosis Proteins 1/2 (cIAP1/2), critical components of the T...
Tallennettuna:
| Julkaisussa: | Oncoimmunology |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6209421/ https://ncbi.nlm.nih.gov/pubmed/30393585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1471440 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|